Reckitt Benckiser Group PLC
http://www.rb.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Reckitt Benckiser Group PLC
RB Predicts 'Challenging' Rest Of Year For OTC Business
Reckitt Benckiser is expecting its OTC sales to be hit by a weak cold and flu season this year, as the social distancing measures introduced to quash the COVID-19 outbreak also disrupt the circulation of seasonal illnesses.
Indivior Must Disband Suboxone Sales Force, Implement Executive Pay Recoupment Program
$600m settlement with DOJ over Suboxone marketing includes corporate integrity agreement and exclusion of subsidiary from government health programs. Indivior also agrees to pay $10m to FTC and be enjoined from future antitrust violations.
People On The Move: Appointments At RB, Angelini And Weleda
Reckitt hires P&G veteran to lead its transformation, while Italy's Angelini and Switzerland's Weleda have new country chiefs.
Nurofen Ad Pulled In NZ For Irresponsible Message During COVID Pandemic
Reckitt Benckiser's TV ad for Nurofen in New Zealand drew numerous complaints for being "socially irresponsible" during the COVID-19 pandemic.
Company Information
- Industry
- Diversified
-
Pharmaceuticals
- OTC, Consumer